ArticleCancer management and research2020

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway.

Xuguang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.